Physician profile
Amanda E White
NPI 1134481377
$528.78
in general payments reported to CMS, 2019-2025
15 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $180 · 2021: $105 · 2022: $23.68 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $111.97 | 2025 | Matrixrib |
| Novo Nordisk INC | $78.61 | 2019-2021 | |
| Lilly USA, LLC | $58.35 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $58.16 | 2020-2021 | |
| Daiichi Sankyo INC. | $45.07 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.40 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $23.68 | 2022 | |
| Amgen INC. | $17.35 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.41 | 2019 | |
| Janssen Scientific Affairs, LLC | $15.35 | 2020 | |
| Dexcom, INC. | $15.06 | 2021 | |
| Ibsa Pharma INC. | $14.51 | 2020 | |
| Pfizer INC. | $14.34 | 2021 | |
| Coopersurgical, INC. | $13.54 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.